These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 3140370)

  • 21. Prostaglandins, NSAIDS, and GI mucosal integrity: can we identify patients at risk of NSAID-induced gastric injury?
    Dajani EZ
    Am J Gastroenterol; 1996 May; 91(5):835-6. PubMed ID: 8633566
    [No Abstract]   [Full Text] [Related]  

  • 22. Gastric mucosal damage by nonsteroidal anti-inflammatory drugs.
    Bennett A
    Int J Tissue React; 1989; 11(2):53-7. PubMed ID: 2693388
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of anti-inflammatory and analgesic pyrazoles on arachidonic acid metabolism in isolated heart and gastric mucosa preparations.
    Coersmeier C; Wittenberg HR; Aehringhaus U; Dreyling KW; Peskar BM; Brune K; Peskar BA
    Agents Actions Suppl; 1986; 19():137-54. PubMed ID: 3092600
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Protection of the gastroduodenal mucosa by prostaglandins.
    Johansson C; Aly A; Befrits R; Smedfors B; Uribe A
    Scand J Gastroenterol Suppl; 1985; 110():41-8. PubMed ID: 3895394
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Gastrointestinal damage from nonsteroidal anti-inflammatory drugs.
    Rainsford KD
    Toxicol Pathol; 1988; 16(2):251-9. PubMed ID: 3142030
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of non-steroidal anti-inflammatory drugs on rat gastric mucosal leukotriene C4 and prostanoid release: relation to ethanol-induced injury.
    Peskar BM; Hoppe U; Lange K; Peskar BA
    Br J Pharmacol; 1988 Apr; 93(4):937-43. PubMed ID: 3390662
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of nonsteroidal anti-inflammatory drugs on endogenous gastrointestinal prostaglandins and therapeutic strategies for prevention and treatment of nonsteroidal anti-inflammatory drug-induced damage.
    Cryer B; Feldman M
    Arch Intern Med; 1992 Jun; 152(6):1145-55. PubMed ID: 1599341
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Inhibition of Helicobacter pylori-induced cyclo-oxygenase-2 aggravates NSAID-caused gastric damage in Mongolian gerbils.
    Futagami S; Hiratsuka T; Wada K; Tatsuguchi A; Tsukui T; Miyake K; Akamatsu T; Hosone M; Sakamoto C; Kobayashi M
    Aliment Pharmacol Ther; 2002 Apr; 16(4):847-55. PubMed ID: 11929405
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Inhibition of prostanoid synthesis by human gastric mucosa.
    Tavares IA; Collins PO; Bennett A
    Aliment Pharmacol Ther; 1987 Dec; 1(6):617-25. PubMed ID: 2979689
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Protective effects of prostaglandins against nonsteroidal anti-inflammatory drug-induced gastrointestinal mucosal injury.
    Dajani EZ; Agrawal NM
    Int J Clin Pharmacol Res; 1989; 9(6):359-69. PubMed ID: 2699464
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Non-steroidal anti-inflammatory drugs and the gastric mucosa: mechanisms of damage and protection.
    Hawkey CJ
    Aliment Pharmacol Ther; 1988; 2 Suppl 1():57-64. PubMed ID: 2979285
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [NSAID and its effect on prostaglandin].
    Toki M; Aoki K; Katsumi N; Takahashi S
    Nihon Rinsho; 2007 Oct; 65(10):1807-11. PubMed ID: 17926528
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Leukotrienes in the pathogenesis of NSAID-induced gastric and intestinal mucosal damage.
    Rainsford KD
    Agents Actions; 1993; 39 Spec No():C24-6. PubMed ID: 8273575
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pharmacological investigation of the role of leukotrienes in the pathogenesis of experimental NSAID gastropathy.
    Vaananen PM; Keenan CM; Grisham MB; Wallace JL
    Inflammation; 1992 Jun; 16(3):227-40. PubMed ID: 1323529
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Metabolism of non-steroidal anti-inflammatory drugs by peroxidase: implication for gastrointestinal mucosal lesions].
    Muraoka S; Miura T
    Yakugaku Zasshi; 2007 Apr; 127(4):749-56. PubMed ID: 17409707
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Overview of gastroduodenal mucosal protection.
    Shorrock CJ; Rees WD
    Am J Med; 1988 Feb; 84(2A):25-34. PubMed ID: 3279766
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Gastrointestinal effects of nonsteroidal anti-inflammatory drugs.
    Whittle BJ
    Fundam Clin Pharmacol; 2003 Jun; 17(3):301-13. PubMed ID: 12803569
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prostaglandins--role in gastric mucosal cytoprotection.
    Sewell RB
    Med J Aust; 1985 Feb; 142 Spec No():S10-3. PubMed ID: 3937961
    [No Abstract]   [Full Text] [Related]  

  • 39. NSAIDs, coxibs, CINOD and H2S-releasing NSAIDs: what lies beyond the horizon.
    Fiorucci S; Santucci L; Distrutti E
    Dig Liver Dis; 2007 Dec; 39(12):1043-51. PubMed ID: 17997373
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Failure of the inhibition of rat gastric mucosal 5-lipoxygenase by novel acetohydroxamic acids to prevent ethanol-induced damage.
    Boughton-Smith NK; Whittle BJ
    Br J Pharmacol; 1988 Sep; 95(1):155-62. PubMed ID: 3146394
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.